The development of a QALY measure for epilepsy: NEWQOL-6D

Epilepsy and Behavior

Volumn 24, Issue 1, 2012, Pages 36-43

  Mulhern, Brendan ^a   Rowen, Donna ^a   Jacoby, Ann ^b   Marson, Tony ^b   Snape, Dee ^b   Hughes, Dyfrig ^c   Latimer, Nick ^a   Baker, Gus A ^b   Brazier, John E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c BANGOR UNIVERSITY   (United Kingdom)

Author keywords

Cost utility analysis; Epilepsy; Factor analysis; Health state valuation; Preference based measure; QALY; Rasch analysis; Resource allocation; Utility

Indexed keywords

ANXIETY; ARTICLE; ATTENTION; ATTITUDE TO ILLNESS; CLINICAL CLASSIFICATION; CONTROL; COST UTILITY ANALYSIS; DEPRESSION; DISEASE SEVERITY; ECONOMIC EVALUATION; EPILEPSY; HEALTH STATUS; HUMAN; MEASUREMENT; MEMORY; PROCESS DEVELOPMENT; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASCH ANALYSIS; RATING SCALE; SCORING SYSTEM; STIGMA; VALIDITY;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; EPILEPSY; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84860700402     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.02.025     Document Type: Article

References (31)

1. National Institute of Health and Clinical Excellence Guide to the methods of technology appraisal 2008, NICE, London.
2. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37(1):53-72.
3. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997, 35(11):1095-1108.
4. Brazier J.E., Roberts J. Estimating a preference-based index from the SF-12. Med Care 2004, 42(9):851-859.
5. Brazier J., Roberts J., Deverill M. The estimation of a preference-based measure of health from the SF 36. J Health Econ 2002, 21(2):271-292.
6. Brazier J., Longworth L. NICE DSU technical support document 8: an introduction to the measurement and valuation of health for NICE submissions 2011, NICE Decision Support Unit, London.
7. Stavem K., Bjornaes H., Lossius M.I. Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy. Epilepsy Res 2001, 44:179-189.
8. Selai C.E., Elstner K., Trimble M.R. Quality of life pre and post epilepsy surgery. Epilepsy Res 2000, 38:67-74.
9. Langfitt J.T., Vickrey B.G., McDermott M.P., et al. Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy. Qual Life Res 2006, 15:899-914.
10. Bockerman P., Johansson E., Saarni S.I. Do established health-related quality-of-life measures adequately capture the impact of chronic conditions on subjective well-being. Health Policy 2011, 100:91-95.
11. Bansback N., Sun H., Guh D.P., et al. Impact of the recall period on measuring health utilities for acute events. Health Econ 2008, 17:1413-1419.
12. Mulhern B., Smith S.C., Rowen D., et al. Improving the measurement of QALYs in dementia: Developing patient and carer reported health state classification systems using Rasch analysis. Value Health 2012, 15(2):323-333.
13. Rowen D., Brazier J.E., Young T., Gaugris S., Craig B.M., King M.T., Velikova G. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health 2011, 14:721-731.
14. Rowen D., Mulhern B., Banerjee S., van Hout B., Knapp M., Smith S., Lamping D., Brazier J. Estimating preference based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value Health 2012, 15(2):346-356.
15. Yang Y., Brazier J., Tsuchiya A., Coyne K. Estimating a preference-based index from the overactive bladder questionnaire. Value Health 2008, 12:59-66.
16. Yang Y., Brazier J.E., Tsuchiya A., Young T. Estimating a preference based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire. Med Decis Making 2011, 31:281-291.
17. Young T.A., Yang Y., Brazier J.E., Tsuchiya A., Coyne K. The first stage of developing preference based measures: constructing a health state classification using Rasch analysis. Qual Life Res 2009, 18(2):253-265.
18. Mulhern B., Rowen D., Brazier J.E., et al. Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report. HEDS Discuss Pap 2010, 10(16):1-31.
19. Abetz L., Jacoby A., Baker G.A., McNulty P. Patient-based assessments of quality of life in newly diagnosed epilepsy patients: validation of the NEWQOL. Epilepsia 2000, 41(9):1119-1128.
20. Jacoby A. Felt versus enacted stigma: a concept revisited: evidence from a study of people with epilepsy in remission. Soc Sci Med 1994, 38:269-274.
21. Baker G.A., Jacoby A., Francis P., Chadwick D.W. The Liverpool adverse drug events profile. Epilepsia 1995, 36:S59.
22. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
23. Jacoby A., Johnson A.L., Chadwick D.W. Psychosocial outcomes of antiepileptic drug discontinuation. Epilepsia 1992, 33:123-131.
24. Pearlin L., Schooler C. The structure of coping. J Health Soc Behav 1978, 19:2-21.
25. Aldenkamp A.P., van Meel H.F., Baker G.A., Brooks J., Hendriks M.P.H. The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests. Seizure 2002, 11(4):231-237.
26. Marson A.G., Al-Kharusi A.M., Alwaidh M., et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazeprine, or topiramate for treatment of partial epilepsy: an unblended randomised controlled trial. Lancet 2007, 369:1000-1015.
27. Marson A.G., Appleton R., Baker G.A., et al. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess 2007, 11(37):1-145.
28. Rasch G. Probabilistic models for some intelligence and attainment tests 1960, University of Chicago Press, Chicago.
29. Brazier J, Rowen D, Mavranezouli I, et al. Developing and testing methods for deriving preference-based measures of health from condition specific measures (and other patient based measures of outcome). Health Technol Assess in press.
30. Linacre J.M. Investigating rating scale category utility. J Outcome Meas 1999, 3(2):103-122.
31. Bjelland I., Dahl A.A., Haug T., Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 2002, 52(2):69-77.